In our latest round-up, we look at Amazon being set to launch ‘Low-Cost Store’, Arm cancelling an IP licence with Qualcomm, ...

Pfizer CEO Albert Bourla is in a tough spot as activist investor Starboard Value continues to call for a change in the ...

Eli Lilly (LLY) said a study of its drug Ebglyss showed it was able to improve skin and itch in patients with atopic ...

Grassi Investment Management lessened its position in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 0.2% in the ...

Boyd Watterson Asset Management LLC OH trimmed its position in Eli Lilly and Company (NYSE:LLY – Free Report) by 9.3% during ...

Eli Lilly and Company has shown rapid growth with significant revenue increases. Click here to find out why I've decided to ...

The company is suing some online vendors and medical spas for selling copycats of a weight loss and diabetes drug.